An overview of extrahepatic cholangiocarcinoma: from here to where?

Front Oncol. 2023 May 1:13:1171098. doi: 10.3389/fonc.2023.1171098. eCollection 2023.

Abstract

Extrahepatic cholangiocarcinoma (eCCA) contains perihilar cholangiocarcinoma and distal cholangiocarcinoma both of which can arise at any point of the biliary tree and originate from disparate anatomical sites. Generally, the incidence of eCCA is increasing globally. Though surgical resection is the principal treatment of choice for the early stages of eCCA, optimal survival remains restricted by the high risk of recurrence when most patients are present with unresectable disease or distant metastasis. Furthermore, both intra- and intertumoral heterogeneity make it laborious to determine molecularly targeted therapies. In this review, we mainly focused on current findings in the field of eCCA, mostly including epidemiology, genomic abnormalities, molecular pathogenesis, tumor microenvironment, and other details while a summary of the biological mechanisms driving eCCA may shed light on intricate tumorigenesis and feasible treatment strategies.

Keywords: extrahepatic cholangiocarcinoma; genomics; pathogenesis; tumor microenvironment; tumorigenesis.

Publication types

  • Review

Grants and funding

This work was supported by grants from the National Natural Science Foundation of China (no. 8210100902) to XZ.